Where Care Excellence Meets Business Success. Transform your operations today - 0333 577 0877
Log in to CareSync Interview Preparation.

Would you like to receive update from CareSync Experts?
Summary, notice description and lot information
The NHS North East and North Cumbria Integrated Care Board is overseeing the procurement process for "QHM-2025-7310 Local Enhanced Services," focused on health services. This process falls under the Health Care Services (Provider Selection Regime) regulations of 2023 and involves a direct award process without prior publication of a call for competition. The contract, awarded to The Sele Medical Group, is intended for health services, including Population Health Management and Immune Modifying Drugs, with a delivery region in the North of England (UKC).
The procurement stage is complete, and the contract was signed on 1st October 2025, with an active status and a nominal value due to its activity-based nature. Services under this contract will span from 1st April 2025 to 31st March 2026, although they are noted to have been operational on an implied contract basis. This procurement opens avenues for businesses skilled in health services, particularly those in the North of England (UKC region), to explore partnership opportunities with the NHS, an influential public body.
The procurement is specifically suited for large-scale or specialised health service providers like The Sele Medical Group that can deliver complex services such as primary care phlebotomy and immune modifying treatments. Businesses looking to diversify into strategic healthcare partnerships could potentially grow by engaging with similar NHS procurement processes, even if the current contract follows a narrow award procedure.
Population Health Management Flu Immunisation (new template to follow for Q3 and Q4 submission) Primary Care System Engagement (contract to follow, including new template for completion) SMI Physical Health Checks Deep Vein Thrombosis Prostate Specific Antigen Primary Care Phlebotomy NTAG Shared Care Services Immune Modifying Drugs Practice Medicine Management The relevant authority intends to award this contract under the Direct Award Process A under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act 2023 and Procurement Regulations 2024 do not apply to this award. The contract value is PS0.01. The contract value cannot be confirmed as the services are activity based contracts with no guaranteed contract value. Contract Start Date: 01 April 2025 Contract End Date: 31 March 2026 Although the contract start is 01/04/2025, the services have been delivered on an implied contract. This is an existing service and existing provider.
Notice type, method, and CPV codes
Financial information and value estimates
Contract duration information not available.
Publication, submission, and award timeline
Current status of tender, lots, awards, and contracts
Buyer organisation and contact details
Supplier who was awarded this contract
External resources and data downloads
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector.
Our expert team can help you prepare a winning bid. Get professional support from CareSync Experts.
Get in touch with our team at Care Sync Experts today for a consultation.
Email: hello@caresyncexperts.co.uk
Phone: 0333 577 0877
Contact Us